Drug Trial Radar · NCT05076838
Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Nov 8, 2021
Primary completion
Mar 11, 2025
Study completion Mar 11, 2025
Sponsor
- Lead sponsor
- Neurelis, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 13, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1/2a, open-label, single-dose, PK study of VALTOCO with open-label safety period in pediatric epilepsy subjects age 2 to 5 years.
Conditions
- Epilepsy
Interventions
Diazepam Nasal Spray [Valtoco]Drug
5 mg, 10 mg, or 15 mg dose of intranasal VALTOCO will be administered based on the subject's body weight.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Plasma Concentration (Cmax) of Diazepam After Intranasal VALTOCO Administered to Subjects With Epilepsy 2 to 5 Years of AgeTime frame: 0-6 hours
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Northwest Florida Clinical Research Group, LLC.
Gulf Breeze, Florida
Nicklaus Children's Hospital
Miami, Florida
AdventHealth Research Institute
Orlando, Florida
Center for Rare Neurological Diseases
Norcross, Georgia
Massachusetts General Hospital
Boston, Massachusetts
University of Missouri Women & Children's Hospital
Columbia, Missouri
Northeast Regional Epilepsy Group
Hackensack, New Jersey
Boston Children's Health Physicians
Hawthorne, New York
University of Rochester
Rochester, New York
Duke University Hospital
Durham, North Carolina
Le Bonheur Children's Hospital
Memphis, Tennessee
UT Southwestern Medical Center
Dallas, Texas
Children's Hospital of the King's Daughters
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.